Scott Smith

Showing 1 posts of 1 posts found.

celgene_1_02

Celgene’s COO heads to the exit

April 3, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing Celgene, Mark Alles, Scott Smith, biotech, drugs, pharma, pharmaceutical

Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …

Latest content